Vacuum Erection Device (VED) segmentation by application delineates four principal use‑cases that collectively shape market demand. The dominant segment, Erectile Dysfunction (ED) treatment, accounts for roughly 65 % of total volume, reflecting the high prevalence of ED in men over 40 and the device’s established clinical efficacy. A second, Post‑Prostatectomy Rehabilitation, contributes about 20 % as urologists prescribe VEDs to restore penile rigidity after radical prostate surgery, a growing niche driven by increasing prostate‑cancer survivorship. The third, General Sexual‑Health Therapy, captures approximately 10 % of sales, encompassing couples‑based interventions and preventive use in men seeking to maintain erectile function. The residual 5 % falls under Other Clinical Applications, such as research protocols and off‑label uses in neuro‑vascular rehabilitation. By quantifying each application’s share, analysts can isolate growth drivers, allocate R&D resources, and forecast revenue streams with greater precision.